Benefits of lifestyle modification in NAFLD
- 1 December 2007
- Vol. 56 (12) , 1760-1769
- https://doi.org/10.1136/gut.2006.112094
Abstract
Compared with our ancestors, Western societies today lead a lifestyle that is much more sedentary, probably as a result of cultural changes stemming from modern socio-economic morays. Taking into account differences in body size, our energy expenditure per kilogram of body weight has been estimated to be –5 Obesity, combined with host factors such as diet, sedentary lifestyle and genetic predisposition, has been directly associated with increases in the prevalence of insulin resistance, diabetes mellitus and the metabolic syndrome. The hepatic manifestation of the metabolic syndrome, NAFLD, has also increased in prevalence, now considered to be around 20–30% in Western countries. Among morbidly obese patients undergoing bariatric surgery, approximately 90% have NAFLD and 36–37% have the more aggressive form of fatty liver, non-alcoholic steatohepatitis (NASH).6 7 In patients with NAFLD, advancing age, increasing weight, the number of features of the metabolic syndrome and the degree of insulin resistance have all been independently associated with NASH severity.8 Evidence-based treatment options for NAFLD are currently lacking. Recent data suggest that the thiazolidinedione class of insulin sensitisers may be efficacious, but widespread utilisation of these agents awaits further investigation.9 Evidence also supports a role for weight loss, achieved through diet and exercise.This publication has 84 references indexed in Scilit:
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJournal of Clinical Investigation, 2007
- The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot StudyDigestive Diseases and Sciences, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disordersThe Journal of Physiology, 2006
- Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseJournal of Hepatology, 2005
- Signalling links in the liver: Knitting SOCS with fat and inflammationJournal of Hepatology, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Hepatic effects of dietary weight loss in morbidly obese subjectsJournal of Hepatology, 1991
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990